✨ Your Portfolio is fetched and updated from zerodha.
Micro Hospitals

Transgene Biotek Ltd.

TRABI

Market Cap
₹30 Cr.
P/E
0.00

Transgene Biotek Ltd.

  • Transgene Biotek
  • Global Longlife Hosp
  • Nidan Labs. & Health
FAQs on Transgene Biotek Ltd. Shareprice

Transgene Biotek has given lower returns compared to its competitors.
Transgene Biotek has grown at ~-34.91% over the last 1yrs while peers have grown at a median rate of -7.0%

There is insufficient historical data to gauge this.
Latest PE of Transgene Biotek is 0

View FAQ's On Business
Growth Table
  • Transgene Biotek Ltd.
  • Global Longlife Hosp
  • Nidan Labs. & Health
Balance Sheet
  • Transgene Biotek Ltd.
  • Global Longlife Hosp
  • Nidan Labs. & Health
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Transgene Biotek Ltd.
  • Global Longlife Hosp
  • Nidan Labs. & Health
Cash Flow
  • Transgene Biotek Ltd.
  • Global Longlife Hosp
  • Nidan Labs. & Health
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Transgene Biotek Ltd.
  • Global Longlife Hosp
  • Nidan Labs. & Health
Quarterly Results
  • Transgene Biotek Ltd.
  • Global Longlife Hosp
  • Nidan Labs. & Health
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Transgene Biotek Ltd. Financials

Transgene Biotek balance sheet is weak and might have solvency issues

Yes, The net debt of Transgene Biotek is increasing.
Latest net debt of Transgene Biotek is ₹14.24 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹13.99 Crs.

The profit is oscillating.
The profit of Transgene Biotek is -₹0.68 Crs for TTM, -₹0.66 Crs for Mar 2024 and -₹6.01 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Transgene Biotek latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech